Knowledge Distillery

COVID-19 pandemic caused relevant psychological consequences in the general population. Since people with Multiple Sclerosis (pwMS) are usually at…

Little is known about trajectories of recovery 12-months after hospitalisation for severe COVID. In this article the authors conducted a prospective,…

The objective of this multi-center, retrospective, cohort study was to estimate the time to recovery of command-following and associations between…

Alzheimer’s disease (AD) and COVID-19 share common risk factors including hypertension. Angiotensin converting enzyme inhibitors (ACEI) and…

Data from the early pandemic revealed that 0.62% of children hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had an…

The authors compared mortality rates in 2020 (March-December) with rates in 2019 for the same period among 53 640 888 Medicare enrollees >…

To determine the impact of MS disease-modifying therapies (DMTs) on the development of cellular and humoral immunity to SARS-CoV-2 infection.

There is strong evidence for brain-related abnormalities in COVID-19. It remains unknown however whether the impact of SARS-CoV-2 infection can be…

Despite the increasing number of reports on the spectrum of neurological manifestations of COVID-19 (neuro-COVID), few studies have assessed short-…

Recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection appears exponential, leaving a tail of patients reporting various…

In this article the authors conducted a systematic review and meta-analysis of the cognitive effects of coronavirus disease 2019 (COVID-19) in adults…

As a global health emergency, the rapid spread of the novel coronavirus disease (COVID‐19) led to the implementation of widespread restrictions (e.g.,…